Search - tctmd.com

Displaying 221 - 240 of 532

Sort: Relevancy | Date

News Daily News

Initial Thrombolysis Found to Be the Most Costly Strategy for Acute Limb Ischemia

September 08, 2014

News Conference News ESC 2014

RITA-3: Advantage of Routine Invasive Strategy for NSTE-ACS Gone by 10 Years

Caitlin E. Cox

September 03, 2014

News Industry News

Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD

September 02, 2014

News Daily News

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

September 02, 2014

News Conference News ESC 2014

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

Caitlin E. Cox

September 02, 2014

News Conference News ESC 2014

FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI

Todd Neale

September 01, 2014

News Conference News ESC 2014

CvLPRIT: Complete Revascularization Halves MACE Risk in STEMI Patients

Caitlin E. Cox

September 01, 2014

News Daily News

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

Todd Neale

August 20, 2014

News Daily News

Intermittent Claudication Patients Have Better Quality of Life With Invasive Treatment

August 20, 2014

News Industry News

Study Published in JACC CI Demonstrates Directional Atherectomy Effective as Frontline Therapy for Peripheral Arterial Disease Patients

August 18, 2014

News Daily News

Updated Stable Ischemic Heart Disease Guidelines Add Advice on Diagnostic Cath

Yael L. Maxwell

August 07, 2014

News Daily News

Meta-analysis: Patient Sex Affects Response to Routine Invasive Approach for NSTE-ACS

Todd Neale

July 30, 2014

News Daily News

STREAM Substudy: Lytic Failure Means Worse Outcomes for Pharmacoinvasively Treated STEMI Patients

July 17, 2014

News Daily News

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

July 08, 2014

News Daily News

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

L.A. McKeown

July 03, 2014

News Daily News

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Yael L. Maxwell

June 17, 2014

News Industry News

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

June 11, 2014

News Daily News

Investigational Stent Graft Shows Promise in EVAR for Infrarenal AAA

L.A. McKeown

June 11, 2014

News Industry News

GSK announces start of phase III cardiovascular outcomes study with losmapimod in patients with acute coronary syndrome

June 05, 2014

News Daily News

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

June 04, 2014

Advertisement

Initial Thrombolysis Found to Be the Most Costly Strategy for Acute Limb Ischemia

RITA-3: Advantage of Routine Invasive Strategy for NSTE-ACS Gone by 10 Years

Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI

CvLPRIT: Complete Revascularization Halves MACE Risk in STEMI Patients

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

Intermittent Claudication Patients Have Better Quality of Life With Invasive Treatment

Study Published in JACC CI Demonstrates Directional Atherectomy Effective as Frontline Therapy for Peripheral Arterial Disease Patients

Updated Stable Ischemic Heart Disease Guidelines Add Advice on Diagnostic Cath

Meta-analysis: Patient Sex Affects Response to Routine Invasive Approach for NSTE-ACS

STREAM Substudy: Lytic Failure Means Worse Outcomes for Pharmacoinvasively Treated STEMI Patients

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

Investigational Stent Graft Shows Promise in EVAR for Infrarenal AAA

GSK announces start of phase III cardiovascular outcomes study with losmapimod in patients with acute coronary syndrome

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content